Cancer

A large audience wearing 3D glasses in a darkened movie theater.
March 23, 2017

Study takes 3-D perspective on colorectal cancer

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

March 21, 2017

Study shows active surveillance preserves quality of life for prostate cancer patients

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).

March 17, 2017

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

March 9, 2017

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.

March 9, 2017

Hockey Fights Cancer

Michelle Alvarez, center, served as patient ambassador for Monroe Carell Jr. Children’s Hospital at Vanderbilt at the recent Nashville Predators Hockey Fights Cancer Night.

February 2, 2017

New target for chronic infection

An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.